SG11201504461QA - Oral transmucosal delivery of glatiramer acetate - Google Patents
Oral transmucosal delivery of glatiramer acetateInfo
- Publication number
- SG11201504461QA SG11201504461QA SG11201504461QA SG11201504461QA SG11201504461QA SG 11201504461Q A SG11201504461Q A SG 11201504461QA SG 11201504461Q A SG11201504461Q A SG 11201504461QA SG 11201504461Q A SG11201504461Q A SG 11201504461QA SG 11201504461Q A SG11201504461Q A SG 11201504461QA
- Authority
- SG
- Singapore
- Prior art keywords
- glatiramer acetate
- transmucosal delivery
- oral transmucosal
- oral
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261745243P | 2012-12-21 | 2012-12-21 | |
| PCT/US2013/077041 WO2014100643A1 (en) | 2012-12-21 | 2013-12-20 | Oral transmucosal delivery of glatiramer acetate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201504461QA true SG11201504461QA (en) | 2015-07-30 |
Family
ID=50979258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201504461QA SG11201504461QA (en) | 2012-12-21 | 2013-12-20 | Oral transmucosal delivery of glatiramer acetate |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150328277A1 (en) |
| EP (1) | EP2934493A4 (en) |
| JP (1) | JP2016503066A (en) |
| KR (1) | KR20150111919A (en) |
| CN (1) | CN104869984A (en) |
| AU (1) | AU2013361057A1 (en) |
| BR (1) | BR112015014092A2 (en) |
| CA (1) | CA2895457A1 (en) |
| EA (1) | EA201591187A1 (en) |
| HK (2) | HK1214133A1 (en) |
| IL (1) | IL239279A0 (en) |
| MX (1) | MX2015007794A (en) |
| SG (1) | SG11201504461QA (en) |
| WO (1) | WO2014100643A1 (en) |
| ZA (1) | ZA201505050B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2627669T3 (en) | 2010-10-11 | 2017-02-28 | Teva Pharmaceutical Industries Ltd. | Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| WO2013055683A1 (en) | 2011-10-10 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate |
| UY35790A (en) | 2013-10-21 | 2015-05-29 | Teva Pharma | GENETIC MARKERS THAT PREACH THE RESPONSE TO THE GLATIRAMER ACETATE |
| US10493122B2 (en) | 2014-03-17 | 2019-12-03 | Mapi Pharma Ltd. | Sublingual delivery of glatiramer acetate |
| CA3067681A1 (en) | 2017-06-26 | 2019-01-03 | Institut Pasteur | Treatments to eliminate hiv reservoirs and reduce viral load |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0679002A (en) * | 1993-12-14 | 1994-03-22 | Hisamitsu Pharmaceut Co Inc | Patch device for percutaneous administration |
| US6197331B1 (en) * | 1997-07-24 | 2001-03-06 | Perio Products Ltd. | Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity |
| ZA200206457B (en) * | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
| US20020077278A1 (en) * | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| US20030175328A1 (en) * | 2002-03-06 | 2003-09-18 | Adi Shefer | Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin |
| JP2006512409A (en) * | 2002-10-31 | 2006-04-13 | ユーエムディー， インコーポレイテッド | A therapeutic composition for drug delivery to and through the coated epithelium |
| ATE433746T1 (en) * | 2004-03-12 | 2009-07-15 | Biodel Inc | INSULIN COMPOSITIONS WITH IMPROVED ACTIVE ABSORPTION |
| FI20041425A0 (en) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmucosal veterinary composition |
| US20060205822A1 (en) * | 2004-12-22 | 2006-09-14 | Forest Laboratories, Inc. | 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect |
| US20060210616A1 (en) * | 2005-03-17 | 2006-09-21 | Linder Barry J | Therapeutic patch for ophthalmologic and cosmetic use |
| US20070021325A1 (en) * | 2005-07-21 | 2007-01-25 | Mediplex Corporation | Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability |
| US20080027011A1 (en) * | 2005-12-20 | 2008-01-31 | Hassan Nached | Homogeneous paste and gel formulations |
| KR100809404B1 (en) * | 2005-12-28 | 2008-03-05 | (주)스피어테크 | The Production Method of Nanodermal Gel which containing Nanowater and transdermal delivery adhensive sheet type Gel |
| US20090136570A1 (en) * | 2006-01-20 | 2009-05-28 | Bhagwant Rege | Taste-Masked Tablets and Granules |
| RU2436565C2 (en) * | 2006-02-17 | 2011-12-20 | Новартис Аг | Disintegrating oral films |
| US20100184848A1 (en) * | 2006-07-14 | 2010-07-22 | William Abraham Wine | Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| BRPI0718360A2 (en) * | 2006-12-04 | 2013-11-12 | Univ Illinois | "COMPOSITIONS AND METHODS FOR CANCER TREATMENT WITH COUPREDOXINS AND RICH DNA IN CPG" |
| CA2689594A1 (en) * | 2007-06-07 | 2008-12-11 | Sato Pharmaceutical Co., Ltd. | Film preparation with rapidly dissolving property and flexibility |
| US20090010998A1 (en) * | 2007-07-03 | 2009-01-08 | Marchitto Kevin S | Drug-delivery patch comprising a dissolvable layer and uses thereof |
| WO2009072572A1 (en) * | 2007-12-06 | 2009-06-11 | Lintec Corporation | Edible film |
-
2013
- 2013-12-20 CN CN201380067117.5A patent/CN104869984A/en active Pending
- 2013-12-20 KR KR1020157019730A patent/KR20150111919A/en not_active Application Discontinuation
- 2013-12-20 AU AU2013361057A patent/AU2013361057A1/en not_active Abandoned
- 2013-12-20 BR BR112015014092A patent/BR112015014092A2/en not_active IP Right Cessation
- 2013-12-20 EA EA201591187A patent/EA201591187A1/en unknown
- 2013-12-20 SG SG11201504461QA patent/SG11201504461QA/en unknown
- 2013-12-20 EP EP13866153.3A patent/EP2934493A4/en not_active Withdrawn
- 2013-12-20 US US14/653,013 patent/US20150328277A1/en not_active Abandoned
- 2013-12-20 MX MX2015007794A patent/MX2015007794A/en unknown
- 2013-12-20 JP JP2015549794A patent/JP2016503066A/en not_active Withdrawn
- 2013-12-20 WO PCT/US2013/077041 patent/WO2014100643A1/en active Application Filing
- 2013-12-20 CA CA2895457A patent/CA2895457A1/en not_active Abandoned
-
2015
- 2015-06-08 IL IL239279A patent/IL239279A0/en unknown
- 2015-07-14 ZA ZA2015/05050A patent/ZA201505050B/en unknown
-
2016
- 2016-02-23 HK HK16102019.5A patent/HK1214133A1/en unknown
- 2016-03-07 HK HK16102543.0A patent/HK1214522A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013361057A1 (en) | 2015-07-30 |
| BR112015014092A2 (en) | 2017-07-11 |
| HK1214133A1 (en) | 2016-07-22 |
| EP2934493A4 (en) | 2016-09-07 |
| HK1214522A1 (en) | 2016-07-29 |
| CA2895457A1 (en) | 2014-06-26 |
| KR20150111919A (en) | 2015-10-06 |
| US20150328277A1 (en) | 2015-11-19 |
| EA201591187A1 (en) | 2016-03-31 |
| WO2014100643A8 (en) | 2015-06-25 |
| WO2014100643A1 (en) | 2014-06-26 |
| JP2016503066A (en) | 2016-02-01 |
| ZA201505050B (en) | 2016-10-26 |
| IL239279A0 (en) | 2015-07-30 |
| CN104869984A (en) | 2015-08-26 |
| EP2934493A1 (en) | 2015-10-28 |
| MX2015007794A (en) | 2015-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2906202A4 (en) | Oral drug delivery formulations | |
| IL236268B (en) | Compositions for transmucosal delivery and uses thereof | |
| HK1214523A1 (en) | Transmucosal delivery of glatiramer acetate | |
| HK1215529A1 (en) | Oral transmucosal drug delivery system | |
| HK1207295A1 (en) | Transmucosal delivery of tocotrienol | |
| HK1199821A1 (en) | Oral pharmaceutical composition | |
| EP2575950A4 (en) | Delivery of oral care products | |
| AU2013344654A1 (en) | Oral transmucosal drug delivery system | |
| HK1199822A1 (en) | Oral pharmaceutical composition | |
| HK1214522A1 (en) | Oral transmucosal delivery of glatiramer acetate | |
| HK1202827A1 (en) | Improvements relating to medicament delivery devices | |
| ZA201502695B (en) | Stable pharmaceutical composition of peginterferon alpha-2b | |
| HK1215668A1 (en) | Caspofungin acetate formulations | |
| PL2908837T3 (en) | Compositions for drug delivery | |
| GB201110632D0 (en) | Drug delivery formulations | |
| GB201121693D0 (en) | Medicament delivery technology | |
| GB201018760D0 (en) | An oral dosage form |